At this year’s IPHASA Symposium held at Mestil Hotel, MU-JHU was represented by Dr. Maxensia Owor who gave a presentation on findings from the IMPAACT 2017 – a study on the long acting Cabotegravir plus Rilpivirine in adolescents with HIV. This was given during the IMPAACT Network Studies section moderated by session chair Prof. Philippa Musoke. During the same session delegates also heard presentations on the IMPAACT P1115 Study delivered by Dr. Adeodata Kekitiinwa and Dr. Violet Korutaro of Baylor Uganda.

IPHASA 2024 Symposium, a global platform for advancing paediatric HIV prevention, care, and treatment across Africa
This symposium is an incredible opportunity to:

• Stay updated on global and regional advances in paediatric HIV
• Learn from diverse country experiences and best practices
• Build expertise in implementation science to drive change